Activities of garlic oil, garlic powder, and their diallyl constituents against Helicobacter pylori

Applied and Environmental Microbiology

Volumn 66, Issue 5, 2000, Pages 2269-2273

  O'Gara, E A ^a   Hill, D J ^a   Maslin, D J ^a  

^a UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIALLYL DISULFIDE; DIALLYL TRISULFIDE; GARLIC OIL;

ANTIBACTERIAL ACTIVITY; ARTICLE; CHRONIC GASTRITIS; DRUG USE; DUODENUM ULCER; GARLIC; HELICOBACTER PYLORI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ALLYL COMPOUNDS; DISULFIDES; GARLIC; HELICOBACTER PYLORI; MICROBIAL SENSITIVITY TESTS; PLANT EXTRACTS; PLANT OILS; PLANTS, MEDICINAL; SULFIDES; SULFINIC ACIDS;

ALLIUM; ALLIUM SATIVUM; HELICOBACTER PYLORI; NEGIBACTERIA;

EID: 0034061472     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.66.5.2269-2273.2000     Document Type: Article

References (31)

1. Bardhan, K. D., H. Wurzer, M. Marcelino, J. Jahnsen, N. Lotay, and P. M. Roberts. 1998. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers. Am. J. Gastroentcrol. 93:380-385.
2. Bayerdröffer, E., A. Neubauer, B. Rudolph, C. Thiede, N. Lehn, and S. Eidt. 1995. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 345:1591-1594.
3. Bell, G. D., K. U. Powell, S. M. Burridge, A. N. Bowden, B. Rameh, G. Bolten, K. Purser, G. Harrison, C. Brown, P. W. Gant, P. H. Jones, and J. E. Trowell. 1993. Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens. Q. J. Med. J. Assoc. Phys. 86:743-750.
4. Buiatti, E., D. Palli, A. Decarli, D. Amadori, C. Avellini, S. Bianchi, R. Biserni, F. Cipriani, P. Cocco, A. Giacosa, E. Marubini, R. Puntoni, C. Vinigni, J. Fraumeni, and W. Blot. 1989. A case control study of gastric cancer and diet in Italy. Int. J. Cancer 44:611-616.
5. Cavallito, C. J., and J. H. Bailey. 1944. Allicin, the antibacterial principle of Allium sativum. I. Isolation, physical properties and antibacterial action. J. Am. Chem. Soc. 66:1950-1954.
6. Cellini, L., E. Di Campli, M. Masulli, S. Di Bartolomeo, and N. Allocati. 1996. Inhibition of Helicobacter pylori by garlic extract (Allium sativum). FEMS Immunol. Med. Microbiol. 13:273-277.
7. Chung, J. G., G. W. Chen, L. T. Wu, H. L. Chang, J. G. Lin, C. C. Yeh, and T. F. Wang. 1998. Effects of garlic compounds diallyl sulphide and diallyl disulphide on arylamine N-acetyltransferase activity in strains of Helicobacter pylori from peptic ulcer patients. Am. J. Chin. Med. 26:353-364.
8. Dixon, M. F. 1992. Helicobacter pylori and chronic gastritis, p. 124-139. In B. J. Rathbone and R. V. Heatley (ed.), Helicobacter pylori and gastroduodenal disease. Blackwell Scientific Publications, Oxford, United Kingdom.
9. Feldman, R. A., A. J. Eccersley, and J. M. Hardie. 1998. Epidemiology of Helicobacter pylori: acquisition, population prevalence and disease-to-infection ratio. Br. Med. Bull. 54:39-53.
10. Fortunatov, M. N. 1955. On the activity of the phytoncides from garlic in the human organism upon peroral administration. Farmakol. Toksikol. 18:43-46.
11. Jonkers, D., E. VandenBroek, I. VanDooren, C. Thijs, E. Dorant, G. Hageman, and E. Stobberingh. 1999. Antibacterial effect of garlic and omeprazole on Helicobacter pylori. J. Antimicrob. Chemother. 43:837-839.
12. Koch, H. P. 1996. Biopharmaceutics of garlic's effective compounds, p. 213-220. In H. P. Koch and L. D. Lawson (ed.), Garlic. The science and therapeutic application of Allium sativum L. and related species. Williams & Wilkins, Baltimore, Md.
13. Koch, H. P. 1996. Toxicity, side effects, and unwanted effects of garlic, p. 221-229. In H. P. Koch and L. D. Lawson (ed.), Garlic. The science and therapeutic application of Allium sativum L. and related species. Williams & Wilkins, Baltimore, Md.
14. Labez, J., and G. Brösch. 1994. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection. Am. J. Gastroenterol. 89:1785-1788.
15. Lawson, L. D. 1998. Garlic: a review of its medicinal effects and indicated active compounds, p. 176-209. In L. D. Lawson and R. Bauer (ed.), Phytomedicines of Europe: their chemistry and biological activity. ACS Symposium Series 691. American Chemical Society, Washington, D.C.
16. Lawson, L. D. 1996. The composition and chemistry of garlic cloves and processed garlic, p. 37-107. In H. P. Koch and L. D. Lawson (ed.), Garlic. The science and therapeutic application of Allium sativum L. and related species. Williams & Wilkins, Baltimore, Md.
17. Lawson, L. D., and B. G. Hughes. 1992. Characterization of the formation of allicin and other thiosulfinates from garlic. Planta Med. 58:345-350.
18. Lawson, L. D., Z. Y. J. Wang, and B. G. Hughes. 1991. Identification and HPLC quantification of the sulfides and dialk(en)yl thiosulfinates in commercial garlic products. Planta Med. 57:36.1-370.
19. Lawson, L. D., S. G. Wood, and B. G. Hughes. 1991. HPLC analysis of allicin and other thiosulfinates in garlic clove homogenates. Planta Med. 57:263-270.
20. Mégraud, F., and H. P. Doermann. 1998. Clinical relevance of resistant strains of Helicobacter pylori: a review of current data. Gut 43(Suppl.):S61-S65.
21. Nomura, A., G. N. Stemmerann, C. Po-Huang, G. I. Péréz-Péréz, and M. J. Blaser. 1994. Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann. Intern. Med. 120:977-981.
22. Ohta, R. 1999. In vitro inhibition of the growth of Helicobacter pylori by oil-macerated garlic constituents. Antimicrob. Agents Chemother. 43:1811-1812.
23. Pasteur, L. 1858. Memoire sur la fermentation appelle lactique. Ann. Chim. Phys. Ser. 52:404-418.
24. Peitz, U., M. Menegalti, D. Vaira, and P. Malfertheiner. 1998. The European meeting on Helicobacter pylori: therapeutic news from Lisbon. Gut 43(Suppl):S66-S69.
25. Pisani, P., D. M. Parkin, N. Munoz, and J. Ferlay. 1997. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol. Biomark Prev. 6:387-400.
26. Reuter, H. D., H. P. Koch, and L. D. Lawson. 1996. Therapeutic effects and applications of garlic and its preparations, p. 135-212. In H. P. Koch and L. D. Lawson (ed.), Garlic. The science and therapeutic application of Allium sativum L. and related species. Williams & Wilkins, Baltimore.
27. Sivam, G. P., J. E. Lampe, B. Ulness, S. R. Swanzy, and J. D. Potter. 1997. Helicobacter pylori - in vitro susceptibility to garlic (Allium sativum) extract. Nutr. Cancer 27:118-121.
28. Stoll, A., and E. Seebeck. 1951. Chemical investigations of alliin, the specific principle of garlic. Adv. Enzymol. 11:377-400.
29. Warren, J. R., and B. Marshall. 1983. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet i:1273-1275.
30. Yoshida, H., N. Iwata, H. Katsuzaki, R. Naganawa, K. Ishikawa, H. Fukuda, T. Fujino, and A. Suzuki. 1998. Antimicrobial activity of a compound isolated from an oil-macerated garlic extract. Biosci. Biotechnol. Biochem. 62:1014-1017.
31. You, W. C., W. J. Blot, Y. S. Chang, A. G. Ershow, Z. T. Yang, Q. An, B. Henderson, G. W. Xu, J. F. Fraumeni, and T. G. Wang. 1988. Diet and high risk of stomach cancer in Shandong. China. Cancer Res. 48:3518-3523.